本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Protagonist Therapeutics Inc

148.18
+3.022.08%
盤前148.180.00000.00%04:50 EDT
成交量:47.80萬
成交額:7,061.77萬
市值:95.88億
市盈率:143.86
高:150.48
開:147.18
低:145.82
收:145.16
52周最高:160.81
52周最低:57.90
股本:6,470.83萬
流通股本:6,316.60萬
量比:0.91
換手率:0.76%
股息:- -
股息率:- -
每股收益(TTM):1.03
每股收益(LYR):-2.0500
淨資產收益率:10.98%
總資產收益率:4.55%
市淨率:11.39
市盈率(LYR):-72.28

資料載入中...

2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/16

重要事件披露

Form 8-K - Current report
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/19

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/02

重要事件披露

Form 8-K - Current report
2023/10/31

重要事件披露

Form 8-K - Current report
2023/08/03

重要事件披露

Form 8-K - Current report
2023/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]